{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:10:49Z","timestamp":1787008249841,"version":"build-2736575974"},"reference-count":24,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To analyze the drug resistance data of carbapenem-resistant\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      (CRKP) collected in 19 tertiary hospitals in the China Antimicrobial Resistance Surveillance Trial Program from 2007 to 2018.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      According to the unified plan, clinical isolates of\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      were collected from 19 tertiary hospitals in 19 cities in mainland China. The minimum inhibitory concentrations (MIC) were determined by a twofold agar dilution method, and antimicrobial susceptibility was established. The isolates were characterized by antimicrobial susceptibility testing, and their drug resistance data were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 302 strains of CRKP were screened from 3,671 strains of\n                      <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                      . The clinical isolation rate of CRKP increased from 0.9% to 19.9% in the past 12 years, and the isolation rate of CRKP in pediatric patients increased the fastest, to 24.7%. Along this period, the isolation rate in the intensive care unit was higher than that in other settings. The number of CRKP strains with imipenem and meropenem MIC \u22648\u2009mg\/L decreased from 63.6% to 11.7% and from 72.7% to 14.2%, respectively. Resistance to drugs that may be used to treat drug-resistant bacterial infections has increased to varying degrees, and CRKP has the lowest resistance rate to polymyxin B (&lt;19.0%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      Because the MIC of CRKP is increasing each year in China, carbapenems are less likely to be used as part of combined therapy to treat CRKP infections. It is difficult to obtain good therapeutic effects against CRKP infections with MICs that are too high. CRKP is still the most sensitive to polymyxin B\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      , followed by tigecycline. Combination therapy may be the most effective current treatment for CRKP infection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/mdr.2019.0299","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T11:30:16Z","timestamp":1581420616000},"page":"944-950","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["Analysis of the Drug Resistance of Carbapenem-Resistant\n                    <i>Klebsiella pneumoniae<\/i>\n                    in the China Antimicrobial Resistance Surveillance Trial Program, 2007\u20132018"],"prefix":"10.1177","volume":"26","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lv","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jiph.2019.01.060","article-title":"Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016\u20132017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies","volume":"12","author":"Ripabelli G.","year":"2019","unstructured":"Ripabelli G., , Salzo A., , Mariano A., , Sammarco M.L, , Tamburro; and Collaborative Group for HAIs Point Prevalence Surveys in Molise Region M.. 2019. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016\u20132017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies. J. Infect. Public Health, 12:509\u2013515.","journal-title":"J. Infect. Public Health"},{"key":"e_1_3_4_3_2","first-page":"241","article-title":"Antimicrobial resistance profile of clinical isolates in hospitals across China: report from the CHINET Surveillance Program, 2017","volume":"18","author":"Fupin H.","year":"2018","unstructured":"Fupin H., , Yan G., , Demei Z., , Fu W., , Xiaofei J., , Yingchun X., , Xiaojiang Z., , Zhaoxia Z., , Ping J., , Yi X., , Mei K., , Chuanqing W., , Aimin W., , Yuanhong X., , Jilu S., , Ziyong S., , Zhongju C., , Yuxing N., , Jingyong S., , Yunzhuo C., , Sufei T., , Zhidong H., , Jin L., , Yunsong Y., , Jie L., , Bin S., , Yan D., , Sufang G., , Lianhua W., , Fengmei Z., , Hong Z., , Chun W., , Yunjian H., , Xiaoman A., , Chao Z., , Danhong S., , Ruizhong W., , Hua F., , Bixia Y., , Yong Z., , Ping G., , Dawen G., , Jinying Z., , Wenen L., , Yanming L., , Yan J., , Chunhong S., , Kaizhen W., , Yirong Z., , Xuesong X., , Chao Y., , Hua Y., , Xiangning H., , Shanmei W., , Yafei C., , Lixia Z., , Juan M., , Shuping Z., , Yan Z., , Lei Z., , Jinhua M., , Fang D., , Hongyan Z., , Han S., , Wanqing Z., , Wei J., , Gang L., , Jinsong W., , Yuemei; and Institute of Antibiotics L., Huashan Hospital, Fudan University. 2018. Antimicrobial resistance profile of clinical isolates in hospitals across China: report from the CHINET Surveillance Program, 2017. Chin. J. Infect. Chemother. 18:241\u2013251.","journal-title":"Chin. J. Infect. Chemother"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-018-1475-3"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"e01882","DOI":"10.1128\/AAC.01882-17","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network","volume":"62","author":"Zhang Y.W.","year":"2018","unstructured":"Zhang Y.W., , Wang Q., , Yin Y.Y, , Chen H.B, , Jin L.Y, , Gu B., , Xie L., , Yang C., , Ma X., , Li H., , Li W., , Zhang X., , Liao K., , Man S., , Wang S., , Wen H., , Li B., , Guo Z., , Tian J., , Pei F., , Liu L., , Zhang L., , Zou C., , Hu T., , Cai J., , Yang H., , Huang J., , Jia X., , Huang W., , Cao B., , and Wang H.. 2018. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob. Agents Chemother. 62:e01882-17.","journal-title":"Antimicrob. Agents Chemother"},{"key":"e_1_3_4_6_2","unstructured":"Clinical and Laboratory Standards Institute. 2019. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 29th ed. CLSI Document M07-A10. CLSI Wayne PA."},{"key":"e_1_3_4_7_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical Breakpoints. EUCAST 2018. Available at www.eucast.org (accessed February7 2020)."},{"issue":"1","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"s28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the Impact and Evolution of a Global Menace","volume":"215","author":"Logan L.K.","year":"2017","unstructured":"Logan L.K., , and Weinstein R.A.. 2017. The epidemiology of carbapenem-resistant Enterobacteriaceae: the Impact and Evolution of a Global Menace. J. Infect. Dis. 215,(Suppl. 1)::s28\u2013s36.","journal-title":"J. Infect. Dis"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-16"},{"key":"e_1_3_4_10_2","first-page":"1","article-title":"Carbapenem-resistant KPC- and TEM-producing Escherichia coli ST131 isolated from a hospitalized patient with urinary tract infection: first isolation in Molise Region, Central Italy, July 2018","volume":"6","author":"Ripabelli G.","year":"2019","unstructured":"Ripabelli G., , Sammarco M.L, , Scutell\u00e0 M., , Felice V., , and Tamburro M.. 2019. Carbapenem-resistant KPC- and TEM-producing Escherichia coli ST131 isolated from a hospitalized patient with urinary tract infection: first isolation in Molise Region, Central Italy, July 2018. Microb. Drug Resist. 6:1\u20138.","journal-title":"Microb. Drug Resist"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/cid\/cis543","article-title":"Carbapenem-resistant Enterobacteriaceae: an emerging problem in children","volume":"55","author":"Logan, L.K","year":"2012","unstructured":"Logan, L.K. 2012. Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin. Infect. Dis. 55:852\u2013859.","journal-title":"Clin. Infect. Dis"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3201\/eid2111.150548","article-title":"Carbapenem-resistant Enterobacteriaceae in children, United States, 1999\u20132012","volume":"21","author":"Logan L.K.","year":"2015","unstructured":"Logan L.K., , Renschler J.P, , Gandra S., , Weinstein R.A, , and Laxminarayan R.. 2015. Carbapenem-resistant Enterobacteriaceae in children, United States, 1999\u20132012. Emerg. Infect. Dis. 21:2014\u20132021.","journal-title":"Emerg. Infect. Dis"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70190-7"},{"issue":"2","key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1093\/cid\/ciy660","article-title":"Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016)","volume":"67","author":"Wang Q.","year":"2018","unstructured":"Wang Q., , Wang X., , Wang J., , Ouyang P., , Jin C., , Wang R., , Zhang Y., , Jin L., , Chen H., , Wang Z., , Zhang F., , Cao B., , Xie L., , Liao K., , Gu B., , Yang C., , Liu Z., , Ma X., , Jin L., , Zhang X., , Man S., , Li W., , Pei F., , Xu X., , Jin Y., , Ji P., , and Wang H.. 2018. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012\u20132016). Clin. Infect. Dis. 67,(Suppl. 2)::S196\u2013S205.","journal-title":"Clin. Infect. Dis"},{"key":"e_1_3_4_15_2","first-page":"116","article-title":"The genotype and epidemiological fearture of the Enterobacteraceae carrying carbapenemase in China","volume":"53","author":"Zhang J.X.","year":"2014","unstructured":"Zhang J.X., , Liu Y.M, , Chen H.B, , Gao H., , Li H., , and Wang H.. 2014. The genotype and epidemiological fearture of the Enterobacteraceae carrying carbapenemase in China. Chin. J. Intern. Med. 53:116\u2013120.","journal-title":"Chin. J. Intern. Med"},{"key":"e_1_3_4_16_2","first-page":"1135","article-title":"Carbapenemase-producing Klebsiella pneumoniae: (when) might westill consider treating with carbapenems? Clin","volume":"17","author":"Daikos G.L.","year":"2011","unstructured":"Daikos G.L., , and Markogiannakis A.. 2011. Carbapenemase-producing Klebsiella pneumoniae: (when) might westill consider treating with carbapenems? Clin. Microbiol. Infect. 17:1135\u20131141.","journal-title":"Microbiol. Infect"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02166-13"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12697"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/QCO.0000000000000109","article-title":"Options for treating carbapenem-resistant Enterobacteriaceae","volume":"27","author":"Petros I.R.","year":"2014","unstructured":"Petros I.R., , and Matthew E.F.. 2014. Options for treating carbapenem-resistant Enterobacteriaceae. Curr. Opin. Infect. Dis. 27:479\u2013483.","journal-title":"Curr. Opin. Infect. Dis"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2016.10.018","article-title":"Might real-time pharmacokinetic\/pharmacodynamic optimisation of high-dose continuous infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Int","volume":"49","author":"Pea F.","year":"2017","unstructured":"Pea F., , Della Siega P., , Cojutti P., , Sartor A., , Crapis M., , Scarparo C., , and Bassetti M.. 2017. Might real-time pharmacokinetic\/pharmacodynamic optimisation of high-dose continuous infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? Int. J. Antimicrob. Agents, 49:255\u2013258.","journal-title":"J. Antimicrob. Agents"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","article-title":"Effect of combination therapy containing a high-dose carbapenem onmortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection","volume":"51","author":"Maddalena G.","year":"2018","unstructured":"Maddalena G., , Enrico M.T, , Daniele R.G, , De Rosa F.G, , Bassetti M., , Bartoloni A., , Bartoletti M., , Losito A.R, , Del Bono V., , Corcione S., , Tedeschi S., , Raffaelli F., , Saffioti C., , Spanu T., , Rossolini G.M, , Marchese A., , Ambretti S., , Cauda R., , Viscoli C., , Lewis R.E, , Viale P., , Tumbarello; Italian Study Group on Resistant Infections of the Societ\u00e0 Italiana Terapia Antinfettiva M.(ISGRI-SITA). 2018. Effect of combination therapy containing a high-dose carbapenem onmortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int. J. Antimicrob. Agents, 51:244\u2013248.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","article-title":"Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014","volume":"22","author":"Hu F.P.","year":"2016","unstructured":"Hu F.P., , Guo Y., , Zhu D.M, , Wang F., , Jiang X.F, , Xu Y.C, , Zhang X.J, , Zhang C.X, , Ji P., , Xie Y., , Kang M., , Wang C.Q, , Wang A.M, , Xu Y.H, , Shen J.L, , Sun Z.Y, , Chen Z.J, , Ni Y.X, , Sun J.Y, , Chu Y.Z, , Tian S.F, , Hu Z.D, , Li J., , Yu Y.S, , Lin J., , Shan B., , Du Y., , Han Y., , Guo S., , Wei L.H, , Wu L., , Zhang H., , Kong J., , Hu Y.J, , Ai X.M, , Zhuo C., , Su D.H, , Yang Q., , Jia B., , and Huang W.. 2016. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014. Clin. Microb. Infect. 22:S9\u2013S14.","journal-title":"Clin. Microb. Infect"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2018.0085"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2016.05.018","article-title":"Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers","volume":"94","author":"Dickstein Y.","year":"2016","unstructured":"Dickstein Y., , Edelman R., , Dror T., , Hussein K., , Bar-Lavie Y., , and Paul M.. 2016. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J. Hosp. Infect. 94:54\u201359.","journal-title":"J. Hosp. Infect"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7196\/SAMJ.2016.v106i9.11028","article-title":"Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: a case series","volume":"106","author":"Malande O.O.","year":"2016","unstructured":"Malande O.O., , Du Plessis A., , Rip D., , Bamford C., , and Eley B.. 2016. Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: a case series. S. Afr. Med. J. 106:877\u2013882.","journal-title":"S. Afr. Med. J"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2019.0299","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2019.0299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:36:29Z","timestamp":1777667789000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2019.0299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1089\/mdr.2019.0299"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2019.0299","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]}}}